McIlrath & Eck’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $145K | Sell |
594
-133
| -18% | -$31K | 0.01% | 317 |
|
|
2025
Q4 | $150K | Buy |
727
+187
| +35% | +$37K | 0.01% | 200 |
|
|
2025
Q3 | $100K | Sell |
540
-17
| -3% | -$2.91K | 0.01% | 217 |
|
|
2025
Q2 | $85.1K | Sell |
557
-94
| -14% | -$14.4K | 0.01% | 222 |
|
|
2025
Q1 | $108K | Buy |
651
+17
| +3% | +$2.66K | 0.01% | 191 |
|
|
2024
Q4 | $91.7K | Sell |
634
-2,258
| -78% | -$350K | 0.01% | 203 |
|
|
2024
Q3 | $469K | Buy |
2,892
+279
| +11% | +$44.5K | 0.06% | 78 |
|
|
2024
Q2 | $382K | Buy |
2,613
+21
| +0.8% | +$3.12K | 0.06% | 79 |
|
|
2024
Q1 | $410K | Buy |
2,592
+64
| +3% | +$10.2K | 0.07% | 75 |
|
|
2023
Q4 | $396K | Buy |
2,528
+10
| +0.4% | +$1.53K | 0.07% | 80 |
|
|
2023
Q3 | $392K | Sell |
2,518
-27
| -1% | -$4.46K | 0.08% | 79 |
|
|
2023
Q2 | $421K | Sell |
2,545
-13
| -0.5% | -$2.1K | 0.09% | 71 |
|
|
2023
Q1 | $396K | Sell |
2,558
-140
| -5% | -$22.6K | 0.09% | 70 |
|
|
2022
Q4 | $477K | Buy |
2,698
+26
| +1% | +$4.49K | 0.12% | 52 |
|
|
2022
Q3 | $436K | Buy |
2,672
+15
| +0.6% | +$2.54K | 0.12% | 54 |
|
|
2022
Q2 | $472K | Buy |
2,657
+224
| +9% | +$39.9K | 0.15% | 42 |
|
|
2022
Q1 | $431K | Hold |
2,433
| – | – | 0.12% | 51 |
|
|
2021
Q4 | $416K | Sell |
2,433
-108
| -4% | -$17.7K | 0.11% | 54 |
|
|
2021
Q3 | $410K | Sell |
2,541
-1,105
| -30% | -$189K | 0.12% | 47 |
|
|
2021
Q2 | $601K | Buy |
3,646
+2
| +0.1% | +$331 | 0.18% | 31 |
|
|
2021
Q1 | $599K | Buy |
3,644
+409
| +13% | +$66.2K | 0.21% | 28 |
|
|
2020
Q4 | $509K | Buy |
3,235
+417
| +15% | +$61.5K | 0.19% | 31 |
|
|
2020
Q3 | $420K | Buy |
2,818
+290
| +11% | +$42.9K | 0.18% | 31 |
|
|
2020
Q2 | $356K | Buy |
2,528
+133
| +6% | +$19.4K | 0.16% | 34 |
|
|
2020
Q1 | $314K | Sell |
2,395
-220
| -8% | -$31.2K | 0.17% | 31 |
|
|
2019
Q4 | $382K | Sell |
2,615
-298
| -10% | -$40.4K | 0.18% | 31 |
|
|
2019
Q3 | $377K | Sell |
2,913
-285
| -9% | -$37.5K | 0.2% | 30 |
|
|
2019
Q2 | $447K | Hold |
3,198
| – | – | 0.25% | 23 |
|
|
2019
Q1 | $447K | Buy |
3,198
+200
| +7% | +$26.8K | 0.25% | 23 |
|
|
2018
Q4 | $387K | Buy |
2,998
+685
| +30% | +$95.6K | 0.25% | 24 |
|
|
2018
Q3 | $320K | Sell |
2,313
-423
| -15% | -$56.2K | 0.18% | 34 |
|
|
2018
Q2 | $332K | Sell |
2,736
-729
| -21% | -$91K | 0.2% | 30 |
|
|
2018
Q1 | $444K | Sell |
3,465
-188
| -5% | -$25.4K | 0.26% | 24 |
|
|
2017
Q4 | $510K | Buy |
+3,653
| New | +$509K | 0.3% | 23 |
|
Other funds holding JNJ
VCM
VPM
McIlrath & Eck's JNJ Position: Q1 2026 in Review
McIlrath & Eck reduced its Johnson & Johnson (JNJ) stake by 18% in Q1 2026, selling an estimated $31K and leaving 594 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #317.
McIlrath & Eck first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $601K in Q2 2021. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- McIlrath & Eck held 594 shares of Johnson & Johnson worth $145K as of Q1 2026.
- McIlrath & Eck sold 133 Johnson & Johnson shares in Q1 2026, an estimated $31K.
- Johnson & Johnson made up 0.01% of McIlrath & Eck's portfolio in Q1 2026, its #317 holding.
- McIlrath & Eck first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- McIlrath & Eck's Johnson & Johnson position peaked at $601K in Q2 2021.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.